Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Impact on production/operations workflows

Pharmaceutical companies are finding that the cost to upgrade a typical packaging line for serialization runs at around $1 million, give or take. With that level of investment, it’s only natural to focus on the equipment and engineering changes involved in reconfiguring the line itself.

However, equally as important to consider are the many changes to standard operating procedures and workflows involved in that line’s operation. Here are a few key considerations:

1. Technician and operator training and SOPs. Because serialization involves additional equipment, typically coding, and inspection and reject stations, mechanics and technicians will need new skills to monitor, maintain, and fix the new equipment that they didn’t have before. The operators will need new training as well. What will success and failure look like, and how will they manage it? What happens when a printer breaks? What happens with rejected product—is it discarded, or opened up and poured back into the hopper? Developing draft SOPs for your pilot may help test the new procedures and facilitate the pilot process.

2. Quality assurance SOPs. Ensure that any unaggregated numbers (due to QA inspections) are de-commissioned at the end of a packaging run.

3. Correcting line issues and machinery jams. Ideally the serialization system should allow an operator to easily correct an issue on the line without having to do a lot of manual processing. This may require companies to revisit the flow of product on a line in order to minimize the possibility of compromising any aggregation points.

While manual overrides aren’t desirable, they must be in place so packaging can continue if equipment goes down. Any time an operator has to manually pack and label a case, the system solution should have checks and balances so operations—including aggregation—can be completed when there is a problem or discrepancy.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging